Design and synthesis of melanocortin peptides with candidacidal and anti-TNF-α properties

Journal of Medicinal Chemistry

Volumn 48, Issue 5, 2005, Pages 1384-1388

  Grieco, Paolo ^a   Rossi, Claudia ^b   Gatti, Stefano ^b   Colombo, Gualtiero ^b   Carlin, Andrea ^b   Novellino, Ettore ^a   Lama, Teresa ^a   Lipton, James M ^c   Catania, Anna ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Zengen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; ESCHERICHIA COLI ENDOTOXIN; MELANOCORTIN; PEPTIDE HORMONE; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SUBSTITUTION; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ESCHERICHIA COLI; MALE; NONHUMAN; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ALPHA-MSH; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; MELANOCYTE-STIMULATING HORMONES; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14944339505     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm040890j     Document Type: Article

References (34)

1. Eberle, A. The melanotropins; Karger: Basel, 1988.
2. Lipton, J. M.; Catania, A. Antiinflammatory actions of the neuroimmunomodulator α-MSH. Immunol. Today 1997, 18, 140-145.
3. Catania, A.; Gatti, S.; Colombo, G.; Lipton, J. M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 2004, 56, 1-29.
4. Luger, T. A.; Brzoska, T.; Scholzen, T. E.; Kalden, D. H.; Sunderkotter, C. et al. The role of α-MSH as a modulator of cutaneous inflammation. Ann. N. Y. Acad. Sci. 2000, 917, 232-238.
5. Ellacott, K. L.; Cone, R. D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 2004, 59, 395-408.
6. Heisler, L. K.; Cowley, M. A.; Tecott, L. H.; Fan, W.; Low, M. J. et al. Activation of central melanocortin pathways by fenfluramine. Science 2002, 297, 609-611.
7. Li, S. J.; Varga, K.; Archer, P.; Hruby, V. J.; Sharma, S. D. et al. Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones. J. Neurosci. 1996, 16, 5182-5188.
8. Dunbar, J. C.; Lu, H. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides 2000, 21, 211-217.
9. Versteeg, D. H.; Van Bergen, P.; Adan, R. A.; De Wildt, D. J. Melanocortins and cardiovascular regulation. Eur. J. Pharmacol. 1998, 360, 1-14.
10. Abdel-Malek, Z.; Scott, M. C.; Suzuki, I.; Tada, A.; Im, S. et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res. 2000, 13 Suppl. 8, 156-162.
11. Hadley, M. E.; Hruby, V. J.; Blanchard, J.; Dorr, R. T.; Levine, N. et al. Discovery and development of novel melanogenic drugs. Melanotan-I and -II. Pharm. Biotechnol. 1998, 11, 575-595.
12. Slominski, A.; Wortsman, J.; Luger, T.; Paus, R.; Solomon, S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 2000, 80, 979-1020.
13. Cutuli, M.; Cristiani, S.; Lipton, J. M.; Catania, A. Antimicrobial effects of α-MSH peptides. J. Leukocyte Biol. 2000, 67, 233-239.
14. Catania, A.; Cutuli, M.; Garofalo, L.; Carlin, A.; Airaghi, L. et al. The neuropeptide α-MSH in host defense. Ann. N. Y. Acad. Sci. 2000, 917, 227-231.
15. Wikberg, J. E.; Muceniece, R.; Mandrika, I.; Prusis, P.; Lindblom, J. et al. New aspects on the melanocortins and their receptors. Pharmacol. Res. 2000, 42, 393-420.
16. Haskell-Luevano, C.; Miwa, H.; Dickinson, C.; Hruby, V. J.; Yamada, T. et al. Binding and cAMP studies of melanotropin peptides with the cloned human peripheral melanocortin receptor, hMC1R. Biochem. Biophys. Res. Commun. 1994, 204, 1137-1142.
17. Mountjoy, K. G.; Robbins, L. S.; Mortrud, M. T.; Cone, R. D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257, 1248-1251.
18. Grieco, P.; Rossi, C.; Colombo, G.; Gatti, S.; Novellino, E. et al. Novel α-melanocyte stimulating hormone peptide analogues with high candidacidal activity. J. Med. Chem. 2003, 46, 850-855.
19. Skottner, A.; Post, C.; Ocklind, A.; Seifert, E.; Liutkevicius, E. et al. Antiinflammatory potential of melanocortin receptor-directed drugs. Ann. N. Y. Acad. Sci. 2003, 994, 84-89.
20. Getting, S. J. Melanocortin peptides and their receptors: new targets for antiinflammatory therapy. Trends Pharmacol. Sci. 2002, 23, 447-449.
21. Szardenings, M.; Muceniece, R.; Mutule, I.; Mutulis, F.; Wikberg, J. E. New highly specific agonistic peptides for human melanocortin MC(1) receptor. Peptides 2000, 21, 239-243.
22. Muceniece, R.; Krigere, L.; Suli-Vargha, H.; Wikberg, J. E. Effects of α-melanotropin C-terminal tripeptide analogues on macrophage NO production. Peptides 2003, 24, 701-707.
23. Hruby, V. J.; Wilkes, B. C.; Hadley, M. E.; Al-Obeidi, F.; Sawyer, T. K. et al. α-Melanotropin: the minimal active sequence in the frog skin bioassay. J. Med. Chem. 1987, 30, 2126-2130.
24. Castrucci, A. M.; Hadley, M. E.; Sawyer, T. K.; Wilkes, B. C.; al-Obeidi, F. et al. α-Melanotropin: the minimal active sequence in the lizard skin bioassay. Gen. Comp. Endocrinol. 1989, 73, 157-163.
25. Sahm, U. G.; Olivier, G. W.; Branch, S. K.; Moss, S. H.; Pouton, C. W. Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides 1994, 15, 1297-1302.
26. Sawyer, T. K.; Sanfilippo, P. J.; Hruby, V. J.; Engel, M. H.; Heward, C. B. et al. 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U. S.A. 1980, 77, 5754-5758.
27. Holder, J. R.; Haskell-Luevano, C. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies. Med. Res. Rev. 2004, 24, 325-356.
28. Ignar, D. M.; Andrews, J. L.; Jansen, M.; Eilert, M. M.; Pink, H. M. et al. Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist. Peptides 2003, 24, 709-716.
29. Taherzadeh, S.; Sharma, S.; Chhajlani, V.; Gantz, I.; Rajora, N. et al. α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. Am. J. Physiol. 1999, 276, R1289-1294.
30. Grieco, P.; Balse-Srinivasan, P.; Han, G.; Weinberg, D.; MacNeil, T. et al. Synthesis and biological evaluation on hMC3, hMC4 and hMC5 receptors of γ-MSH analogs substituted with L-alanine. J. Pept. Res. 2002, 59, 203-210.
31. Holder, J. R.; Xiang, Z.; Bauzo, R. M.; Haskell-Luevano, C. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg position. Peptides 2003, 24, 73-82.
32. Yang, Y. K.; Fong, T. M.; Dickinson, C. J.; Mao, C.; Li, J. Y. et al. Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 2000, 39, 14900-14911.
33. Yang, Y.; Dickinson, C.; Haskell-Luevano, C.; Gantz, I. Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor. J. Biol. Chem. 1997, 272, 23000-23010.
34. Commission on Life Sciences, N. R. C. Guide for the Care and Use of Laboratory Animals; The National Academy Press: Washington, DC, 1996.